The exposure of CXCR4- and CXCR7-positive lymphoma cells to CXCL12 greatly potentiates their trans-endothelial migration, and this CXCL12-potentiated transendothelial migration is inhibited by blocking CXCR7 [17]. The gene discussed is ACKR3; the disease is lymphoma.